None listed
Conditions
Interventions
None listed
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed and treatment-naïve multiple myeloma, smoldering myeloma, plasma cell leukemia, or solitary plasmacytoma 2. Patients over 19 years old 3. Patients who agree to participate the study with written consent
Exclusion criteria
Exclusion criteria: 1. Patients who neither understand nor agree with written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival and Progression-free survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall response according to primary or salvage treatment (overall response rate), Progression-free survival following respective primary or salvage treatment, Trend of treatment according to physician, Identifying variables associated with survival, Identifying prognostic factors, Clinical characteristics when disease is progressed/relapsed | — |
Countries
Korea, Republic of
Contacts
Public ContactJi-Hyung Kim
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed